Bing Chen
14Patents
1h-index
23Co-inventors
50Inventor score
Filing activity: Aug 27, 2010 → May 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8779105B2 | Monoclonal antibodies to programmed death 1 (PD-1) | Emerging Cross-Sectional Technologies | 204 | Active |
| US10463729B2 | Biochemically stabilized HIV-1 env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US9950060B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US10307478B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US11369690B2 | Bi-specific antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8741310B2 | Fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US12064425B2 | Compositions and methods for targeting a viral infection | Chemistry; Metallurgy | 0 | Active |
| US11040111B2 | Bi-specific antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9707289B2 | Biochemically stabilized HIV-1 ENV trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US10653770B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US11229696B2 | Biochemically stabilized HIV-1 Env trimer vaccine | Chemistry; Metallurgy | 0 | Active |
| US11773385B2 | High-affinity human ACE2 construct for use in diagnosing and treating coronaviruses | Physics | 0 | Active |
| US10675346B2 | Antigenic polypeptides comprising pre-hairpin intermediate conformations of HIV-1 GP41 | Physics | 0 | Active |
| US10188742B2 | Bi-specific antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.